Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 84 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
831 13.1 months Hepatocellular carcinoma 5 Chemotherapy
California Pacific Medical Center United States 9/2009
Treatment Details: Patients: This phase 2 study involved hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A had 14 patients with an average age of 59.2 years and 7
 
832 13.1 months Metastatic colorectal carcinoma 4 Biologic therapy
Istituto Clinico Humanitas Italy 10/2010
Treatment Details: Patients: This phase 2 study involved 33 previously-treated metastatic colorectal cancer patients with a median age of 65 years; 48.5% of the patients were male. Treatment: Patients wer
 
833 13.1 months Advanced urothelial carcinoma 4 Chemotherapy
Akita University School of Medicine Japan 10/2011
Treatment Details: Patients: This phase 2 study involved 35 advanced urothelial carcinoma patients. The median patient age was 68 years and 82.9% were male. Treatment: Patients were treated with the chem
 
834 13.1 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
University Hospital Gasthuisberg Belgium 4/2011
Treatment Details: Patients: This phase II study involved previously treated metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 426 patients with
 
835 13.1 months Malignant pleural mesothelioma 5 Chemotherapy
Surgery
Brigham and Women's Hospital United States 8/2009
Treatment Details: Patients: This phase 2 study involved 92 patients with malignant pleural mesothelioma. The majority (79%) were men. Their median age was 60, ranging from 27 to 78 years of age. Treat
 
836 13.1 months Advanced hepatocellular carcinoma 4 Biologic therapy
Chiba University Hospital Japan 2/2011
Treatment Details: Patients: This study involved 35 patients with advanced hepatocellular carcinoma. The median age of the group was 68 years and 29 were male. Treatment: Patients were treated with the b
 
837 13.1 months Platinum resistant ovarian cancer 4 Biologic therapy
Chemotherapy
University MedicalCenter Utrecht Cancer Center Netherlands 11/2010
Treatment Details: Patients: This study involved 26 women with platinum-resistant ovarian cancer. The median age was 60 years. Treatment: Patients were treated with the chemotherapy agent pegylated lipos
 
838 13.0 months Malignant pleural mesothelioma 5 Chemotherapy
Karolinska University Hospital Sweden 11/2008
Treatment Details: Patients: This phase 2 study involved 173 patients with malignant pleural mesothelioma who had not received prior chemotherapy. The mean patient age was 62.8 years and 90.8% were male.
 
839 13.0 months Metastatic melanoma 4 Biologic therapy
Chemotherapy
University of Sydney at Westmead Hospital Australia 3/2010
Treatment Details: Patients: This study involved patients with metastatic melanoma who had not received prior chemotherapy. Patients were separated into two separate treatment groups. Group A had 40 patient
 
840 13.0 months NSCLC 5 Chemotherapy
Emory University United States 1/2010
Treatment Details: Patients: In this study, patients with advanced non-small-cell lung cancer were divided into two treatment groups. Group A consisted of 62 patients with a median age of 64 years, 61% of wh
 
Page 84 of 187  | Previous Page  | Next Page